Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

09/02/2017 ​Hepatitis C Under the Watchful of ALBA Synchrotron 02/02/2017 ​The Barcelona Entrepreneurial Spirit Attracts Important Rounds of Funding 26/01/2017 ​SENER, 50 Years In Space! 19/01/2017 Barcelona Synchrotron Park Even Closer 11/01/2017 ALBA Synchrotron Is Also a Tool for the Environment 05/01/2017 ​Barcelona & Catalonia Startup Hub, the Catalan startups showcase
19 20 21 22 23 24 25 26 27 28 29